Australian clinicians' perceptions of patients with very high risk of fracture
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Christian M Girgis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Osteoporotic Fractures, Osteoporosis, Bone Density Conservation Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
International osteoporosis guidelines have recommended treatment approaches based on fracture risk stratification, in particular, anabolic therapy for patients with very high risk (VHR) of fragility fracture.
Aim
To summarise Australian clinicians' perceptions of patients at VHR of fracture.
Methods
Australian clinicians invited to educational webinars on anabolic treatments for osteoporosis were surveyed in March and April 2021 about a typical patient they had most recently seen and identified as at VHR of fracture.
Results
Of the 268 clinician attendees who were invited to complete the post‐webinar surveys, 67 (25%) responded and permitted the publication of aggregated data. A typical patient perceived to have a VHR of fracture was a woman in her 80's, living at home, who had been diagnosed with osteoporosis between 5 and 10 years ago, and received treatment for 1–5 years' duration, most commonly denosumab. The patient frequently had a T ‐score below −3.0 SD (standard deviation), multiple fragility fractures and most commonly suffered a vertebral fracture in the past 12 months, whereas on an adequate regimen of osteoporosis medication. There was a mismatch between the patient being eligible for anabolic therapy (64.2%) and actually having been prescribed an anabolic treatment in the past (20.9%).
Conclusions
Australian clinicians' perceptions of patients with a VHR of fracture and the use of anabolic agents appear to be heavily influenced by local reimbursement criteria. The mismatch between patients deemed eligible for reimbursed anabolic therapy and those prescribed an anabolic agent suggests treatment inertia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia.
- Evidencia Medical Communications Pty Ltd, Sydney, New South Wales, Australia.
- Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Christian M Girgis
Zitieren
APA
Girgis, C. M., Choi, Y., & Ebeling, P. R. (2024). Australian clinicians' perceptions of patients with very high risk of fracture. Internal Medicine Journal. https://doi.org/10.1111/imj.16317
Vancouver
Girgis CM, Choi Y, Ebeling PR. Australian clinicians' perceptions of patients with very high risk of fracture. Internal Medicine Journal. 2024. doi:10.1111/imj.16317
BibTeX
@article{Girgis2024,
author = {Girgis, Christian M and Choi, Yoonah and Ebeling, Peter R},
title = {Australian clinicians' perceptions of patients with very high risk of fracture},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16317}
}
EUVIMED